Related Experiment Video

Updated: Jun 26, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Percutaneous coronary interventions and statins therapy

Annunziata Nusca1, Rosetta Melfi, Germano Di Sciascio

  • 1g.disciascio@unicampus.it

Therapeutic Advances in Cardiovascular Disease
|January 7, 2009
PubMed

Insights

Statins significantly reduce heart damage and kidney injury in patients undergoing percutaneous coronary intervention (PCI). This evidence supports the use of statins to improve outcomes after PCI procedures.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Pharmacology

Background:

  • Statins offer cardioprotective effects by improving endothelial function and stabilizing atherosclerotic plaques.
  • Periprocedural myocardial infarction and contrast-induced nephropathy negatively impact long-term outcomes following percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate the efficacy of statin pretreatment and acute loading in mitigating periprocedural myocardial infarction and contrast-induced nephropathy in patients undergoing PCI.
  • To assess the impact of statins on endothelial function and adhesion molecule expression.

Main Methods:

  • Review of randomized trials, including ARMYDA, ARMYDA ACS, and ARMYDA-CAMS, investigating statin use before and during PCI.
  • Analysis of outcomes such as periprocedural myocardial infarction, contrast-induced nephropathy, and changes in adhesion molecules (ICAM-1, E-Selectin).

Main Results:

  • Statin pretreatment before elective PCI reduces periprocedural myocardial infarction in stable angina patients.
  • High-dose atorvastatin loading prevents myocardial damage in acute coronary syndrome patients undergoing early PCI.
  • Statins reduce the incidence of contrast-induced nephropathy in patients undergoing PCI.

Conclusions:

  • Statin therapy, both pre-procedural and acute loading, demonstrates significant benefits in reducing adverse events associated with PCI.
  • The findings suggest a strong influence of statins on clinical practice for interventional cardiologists.
  • Statins modulate key pathways, including oxidative stress, inflammation, and adhesion molecule expression, contributing to improved patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...